B.J. Maurer
B.J. Maurer
Unknown affiliation
Verified email at ttuhsc.edu
Title
Cited by
Cited by
Year
Ceramide synthesis and metabolism as a target for cancer therapy
CP Reynolds, BJ Maurer, RN Kolesnick
Cancer letters 206 (2), 169-180, 2004
4142004
Retinoid therapy of high-risk neuroblastoma
CP Reynolds, KK Matthay, JG Villablanca, BJ Maurer
Cancer letters 197 (1-2), 185-192, 2003
3362003
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
BJ Maurer, LS Metelitsa, RC Seeger, MC Cabot, CP Reynolds
Journal of the National Cancer Institute 91 (13), 1138-1146, 1999
3151999
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl) retinamide and modulators of ceramide metabolism
BJ Maurer, L Melton, C Billups, MC Cabot, CP Reynolds
Journal of the National Cancer Institute 92 (23), 1897-1909, 2000
2422000
N-(4-hydroxyphenyl) retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase
H Wang, BJ Maurer, CP Reynolds, MC Cabot
Cancer research 61 (13), 5102-5105, 2001
1542001
Evaluating response to antineoplastic drug combinations in tissue culture models
CP Reynolds, BJ Maurer
Chemosensitivity, 173-183, 2005
1432005
Retinoic‐acid‐resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide
CP Reynolds, Y Wang, LJ Melton, PA Einhorn, DJ Slamon, BJ Maurer
Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2000
1032000
N-(4-Hydroxyphenyl) retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
H Wang, BJ Maurer, YY Liu, E Wang, JC Allegood, S Kelly, H Symolon, ...
Molecular cancer therapeutics 7 (9), 2967-2976, 2008
1012008
Fenretinide cytotoxicity for Ewing’s sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators
S Batra, CP Reynolds, BJ Maurer
Cancer research 64 (15), 5415-5424, 2004
982004
N-(4-hydroxyphenyl) retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes
PH O'Donnell, WX Guo, CP Reynolds, BJ Maurer
Leukemia 16 (5), 902-910, 2002
922002
Novel submicroscopic extrachromosomal elements containing amplified genes in human cells
BJ Maurer, E Lai, BA Hamkalo, L Hood, G Attardi
Nature 327 (6121), 434-437, 1987
851987
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
B Wingelhofer, B Maurer, EC Heyes, AA Cumaraswamy, A Berger-Becvar, ...
Leukemia 32 (5), 1135-1146, 2018
772018
Improved oral delivery of N-(4-hydroxyphenyl) retinamide with a novel LYM-X-SORB organized lipid complex
BJ Maurer, O Kalous, DW Yesair, X Wu, J Janeba, V Maldonado, ...
Clinical Cancer Research 13 (10), 3079-3086, 2007
692007
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to …
BJ Maurer, MH Kang, JG Villablanca, J Janeba, S Groshen, KK Matthay, ...
Pediatric blood & cancer 60 (11), 1801-1808, 2013
632013
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells
AK Jayavelu, JP Müller, R Bauer, SA Böhmer, J Lässig, S Cerny-Reiterer, ...
Leukemia 30 (2), 473-483, 2016
602016
Treatment of hyperproliferative disorders
BJ Maurer, M Cabot, CP Reynolds
US Patent 6,352,844, 2002
572002
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
A Schrader, G Crispatzu, S Oberbeck, P Mayer, S Pützer, J von Jan, ...
Nature communications 9 (1), 1-22, 2018
472018
Human dihydrofolate reductase gene is located in chromosome 5 and is unlinked to the related pseudogenes
BJ Maurer, PE Barker, JN Masters, FH Ruddle, G Attardi
Proceedings of the National Academy of Sciences 81 (5), 1484-1488, 1984
461984
STAT5BN642H is a driver mutation for T cell neoplasia
HTT Pham, B Maurer, M Prchal-Murphy, R Grausenburger, ...
The Journal of clinical investigation 128 (1), 387-401, 2018
432018
Treatment of hyperproliferative disorders
BJ Maurer, M Cabot, CP Reynolds
US Patent 6,352,844, 2002
432002
The system can't perform the operation now. Try again later.
Articles 1–20